The IP series features guest speakers who will provide an overview of the different types of intellectual property (IP), updates on the latest changes in the IP landscape, and impact on strategies for protecting Cornell IP.
Programs & Outreach IP Series
Upcoming Events
Are you interested in more CTL events? You can visit our events page here to get information about upcoming events and registration links.
Past Events
IP Series: Navigating the IP Maze in AI Technologies
March 7, 2024
This virtual event focused on securing IP rights for AI-related technologies. We explored the deep ideas with Jason Novak, Partner at Norton Rose Fulbright, specializing in Precision Medicine and Digital Health, alongside Douglas Link, a Member at Cozen O’Connor. They provided invaluable insights into obtaining IP protection and navigating the patent landscape in the digital health and AI sectors.
IP Series 2: U.S. Regulatory Requirements for Gene-Edited Plants
October 26, 2023
During this hybrid event, we discussed:
- How USDA, FDA, and EPA work together to regulate gene edited plants and foods produced therefrom
- Strategic considerations for addressing USDA’s SECURE rule
- The EPA’s new rules for Plant Incorporated Protectants (PIPS) created by gene editing.
CTL IP Series 1: Understanding the Technology Transfer Process
September 27, 2023
For this first of the season series, the CTL team presented the technology transfer process at Cornell and will outline the groups at CTL (Ithaca and Weill Cornell in NYC) and the resources available to the research community, University Technology Transfer – Bayh-Dole Act, Patent Law Primer, and Marketing and Evaluating Your Invention.
CTL IP Series 5: IP Strategies for Protecting and Commercializing Biotech Inventions
June 21, 2023
This IP series provided an overview of Biotech IP and commercialization strategies rooted in patent prosecution. During this fifth series, Eric Bryant, Intellectual Property officer at CTL, was joined by Yvonne Shyntum, Partner at Pabst Patent Group.
CTL IP Series 4: From Invention Disclosures to Issued Patents: An Inventor Perspective
April 20, 2023
This panel session aims to provide clarity and guidance by exploring the process from the perspective of an active inventor, Robert F. Shepherd, Associate Professor at Cornell University. Paul Roman, Partner at Johnson, Marcou, Isaacs & Nix, LLC, also joined him to provide a couple of examples from Shepherd’s IP portfolio and share best practices for successful patent applications.
CTL IP Series 3: Software & Copyright
February 9, 2023
For this third installment of the IP Series, learn about software inventions and the copyright and patent strategies to protect them. Our experts from Ryan, Mason & Lewis, LLP delved into the definitions and practical case studies of legal challenges and infringements as well as the impact of some cases on the sector (e.g., Alice Corp. Pty. Ltd. v. CLS Bank Int’l).
CTL IP Series 2: What Makes Patents Commercially Relevant?
November 9, 2022
For this second session of the IP Series, Lisa Placanica, Senior Managing Director, and Eric Bryant, IP Officer at the Center for Technology Licensing at Weill Cornell Medicine, took a deep dive into key elements researchers should consider when working with CTL on the prosecution of their patent applications which will help make their IP commercially relevant.
CTL IP Series 1: Understanding the Technology Transfer Process
September 15, 2022
For this first of the season series, the CTL team presented the technology transfer process at Cornell and will outline the groups at CTL (Ithaca and Weill Cornell in NYC) and the resources available to the research community, University Technology Transfer – Bayh-Dole Act, Patent Law Primer, and Marketing and Evaluating Your Invention.
CTL IP Series 3: Successful Patent Applications–It’s All in the Timing
April 20, 2022
During the third installment of the IP Series, experts in intellectual property discussed real-life examples of practical considerations in invention disclosure timing, including enablement, written description and the hazards of prior art in publishing scientific findings before patenting.
CTL IP Series 2: Why are diagnostic claims so hard to get (in the US)?
February 17, 2022
During this second IP series, Troutman Pepper and CTL executives addressed the challenges of protecting diagnostic innovations in the United States. This talk provided insights into the patent eligibility limitations in this field, the strategies to overcome them, and the important aspects to consider as an inventor when you disclose to the CTL office.
CTL IP Series 1 (Bis): Understanding the Technology Transfer Process
October 26, 2021
For this first of the season series, the CTL team presented the technology transfer process at Cornell and will outline the groups at CTL (Ithaca and Weill Cornell in NYC) and the resources available to the research community, University Technology Transfer – Bayh-Dole Act, Patent Law Primer, and Marketing and Evaluating Your Invention.
CTL IP Series 3: Software, Copyright, and Trademark
April 22, 2021
This IP series provided an overview of the different types of intellectual property (IP), updates on the latest changes in the IP landscape and impact on strategies for protecting Cornell IP. During this third series, Bill Pegg, Associate Director for IP at CTL was joined by two IP Attorneys at Ryan, Mason & Lewis, LLP.
CTL IP Series 2: What is Patent Eligible in the U.S.?
March 19, 2021
For this second virtual meeting of the IP series, Dr. John D. Lopinski, Partner at Hodgson Russ LLP, presented an overview of patent eligible subject matter and provided some examples to illustrate issues related to patent eligibility.
CTL IP Series 1: Understanding the Technology Transfer Process
February 19, 2021
For this first of the season series, the CTL team presented the technology transfer process at Cornell and will outline the groups at CTL (Ithaca and Weill Cornell in NYC) and the resources available to the research community, University Technology Transfer – Bayh-Dole Act, Patent Law Primer, and Marketing and Evaluating Your Invention.
